Share Your Work at xMAP® Connect Amsterdam!

Luminex is seeking abstract submissions for poster presentations at xMAP® Connect 2018. Please submit your abstract to the left. Please follow the guidelines below and use this outline.

Abstract Submission Guidelines

Abstract text should include all the items listed below and is limited to 3,000 characters (approximately 500 words) not including spaces:

  • A title
  • The author(s) and institution(s) involved in your proposed article
  • An introductory sentence indicating the purposes of the study
  • A brief description of pertinent experimental procedures
  • Which xMAP product(s) are used in your method
  • A summary of the new, unpublished data
  • A statement of the conclusions
  • A statement as to how xMAP Technology has enabled your research

If you have any questions about xMAP Connect, email europe@luminexcorp.com.

Click here to learn more about xMAP Connect 2018 in Amsterdam.

Agreement Upon Submission

* By submitting an abstract, you agree to the following terms and conditions:

I agree to be present the 8th and 9th of November in Amsterdam, should your abstract be selected.

This submission has been approved by all authors and serves to grant Luminex an irrevocable license to use the abstract and poster in connection with the xMAP Connect meeting. The authors accept sole responsibility for the statements in their abstracts. The authors are submitting an original abstract and, if selected, will present an original poster with accompanying media figures during the xMAP Connect meeting. The authors warrant this content is their own creation and is 100% original work; is not subject to, and does not infringe upon, the rights of any third parties, including without limitation privacy or publicity rights; and is not defamatory, obscene, or otherwise illegal. If “non-original” text or media of any kind is used, the authors certify permission has been granted by the authors, creators, or publishers of that content.

Selected abstracts must meet minimum Luminex assay quality criteria. Abstracts will be evaluated on the basis of: impact to the field, scientific content, concept/novelty, use of techniques, and value to the scientific community. The submissions meeting these criteria will be selected to present posters during the xMAP Connect meeting.

Entrants not complying with the above requirements will be subject to disqualification.

Accepted Posters
Number Abstract
1 Stephan Michalik
xMAP® – An App to Analyze, Visualize, and Inspect Dilution-base Serological Assay Using the xMAP Technology
View Abstract
2 Premnath Rajakannu
Multiplexing Protein and Gene Level Measuements on a Single Luminex Platform
View Abstract
3 Tatiana Suslova
Detection of Cytokines and Chemokines in Supernatants and Blood Serum of Patients with Diabetes Mellitus Type 2 by Multiplex Analysis
View Abstract
4 Anna Gusakova
Application of the Multiplexed Immunoassays in the Comprehensive Assessment of Cardiovascular Biomarkers Dynamics in Patients with Acute Primary Anterior Myocardial Infarction with ST Segment Elevation
View Abstract
5 Laurie Stephen
Stability of Zika and Dengue Immunoglobulines in Matched Serum and Uring Samples as Assessed Using a 15-plex Commercial Kit for the Detection IgG and IgM to Zika and Other Flaviviruses
View Abstract
6 Mathilda Dale
Designing Sandwich Assay Workflows for Large Scale Studies of Plasma Biobanks
View Abstract
7 Richard K. Fuerstenberg (Bio-Techne)
Improved Accuracy in Multiplex Assays by Elimination of False Positives Due to Endogenous Antibodies
View Abstract
8 Scott Altmann
Protein Dense Lipoproteins: The Unimagined Biomarker for Human Health Assessment
View Abstract
9 Brooke Gilliam (Merck)
Multiplex Immunoassay Detection of Autoimmune Disease Autoantibodies in Serum and Plasma
View Abstract
10 Philippa Pettingill
Generation of a Validated Suspension Bead Array Assay for Exploratory and High-throughput Profiling of Human Plasma
View Abstract
11 Wen-Rong Lie (Merck)
Quantitative Multiplex Analysis of Immune Checkpoint Protein Expression in Circulation and in the Tumor Microenvironment
View Abstract
12 Siphesihle Mdlalose
The Role of Folllistatin in HIV-associated Pre-eclampsia
View Abstract
13 Helena Kupcova Skalnikova
Profiling of Blood Cytokines in Melanoma Patients and Porcine Melanoma Model: Search for Positive/Negative Prognostic Markers
View Abstract
14 Liza Portier
Bead-based Multiplex Technology for the Simultaneous, Fast, and Portable On-site Detection of Different Food Contaminants
View Abstract
15 Mansour Harsini
Evaluation of Protein Biomarkers in Wound Fluid for Rediction Wound Healing in Diabetic Foot Ulcers by Luminex Assay
View Abstract
16 Elizabeth Dreskin (Bio-Rad)
Profiling Apolipoproteins in Disease
View Abstract
17 Salvatore Pernagallo
A Breakthrough PCR-free Technology for Diagnosing Liver Injury
View Abstract
18 Csilla Nemes
Identification of Potential Biomarkers Useful in Differentation COPD from Asthma
View Abstract
19 Tadeja Kuret
Development of a Novel Bead-based Luminex Assay for Simultaneous Detection of Autoantibodies Against Acute Phase Proteins
View Abstract
20 Solveig Konings
Cancer Immunotherapy Array: A Novel Screening Tool For Immune System Profiling in Cancer Immunotheraphy Bridging Autoimmunity and Cancer
View Abstract
21 Jan Rožanc (ProtAtOnce)
Multiplex Phosphoproteomic Profiling Predicts Trametinib Responsiveness and Optimal Trametinib Sensitization Strategies in Melanoma
View Abstract
22 Christian Raue
Is Your Data Normally Distributed?
View Abstract
23 Natalia Lyubimova
The Concentration of Some Chemokines in Blood Plasma in Healthy Donors
View Abstract
24 Natalya Arsentieva
Chemokines as the Biomarkers of Chronic Hepatitis with Different Etiology
View Abstract
25 Tatiana Radygina
Biomarkers of Biological Therapy Inefficiency in Children with Inflammatory Bowel Diseases
View Abstract
26 Svetlana Apalko
The Role of Multiplexed Assays in Characterizing Samples from the Clinical Biobank
View Abstract
27 Abigail Bell
Findings and Updates from the Multiplex Immunoassay Consortium
View Abstract
28 Anastaciia Boiko
Metabolic Syndrome of Patients with Schizophrenia and Spectrum of Apolipoproteins in Blood Serum
View Abstract
29 Stefano Bonacci
Development of an Integrated Luminex-Hamilton Platform for High-Throughput Multiplexed Immuno Assays
View Abstract
30 Ezra Linley
Should Pneumococcal Serotype 3 Be Included in Sero-Type Specific Immunoassays
View Abstract
31 Wojciech Swidzinski
Transforming Routine Laboratory Developed Tests Using Hydrolysis Probe Chemistry into Cassette Based Molecular Assays for use on the Luminex ARIES® System
View Abstract
32 Sandra Mükusch
Unraveling antibody specificity via multiple complementary approaches
View Abstract
33 Séverine Giltaire
Cytokine detection and measurement with Multiplex Technologies in the context of a cytokine secretion assay
View Abstract
34 Ciska Lindelauf
Cytokine profiles during the recovery phase of rituximab treatment in patients with interstitial pneumonitis
View Abstract
35 Celine Merg
The impact of exposure to cigarette smoke on the secreton of inflammatory mediators: assessment using human organotypic small airway epithelial cultures from five different donors
View Abstract

Submit Your Abstract